279 Predictive factors of postoperative complications after cytoreductive surgery for ovarian cancer

• Published in: International journal of gynecological cancer Vol. 29; no. Suppl 3; pp. A117 - A118
• Main Authors: Atallah, D, Sarkis, Y, Richa, F, Sleilaty, G, Moubarak, M, El Kassis, N, Chahine, G, Chalhoub, V
• Format: Journal Article
• Language: English
• Published: Oxford by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology 01.09.2019; BMJ Publishing Group LTD
• Subjects: Chemotherapy; Intensive care; Ovarian cancer; Surgery
• ISSN: 1048-891X; 1525-1438
• DOI: 10.1136/ijgc-2019-IGCS.279

ObjectivesOvarian cancer is the leading cause of death from gynecological cancer for women. The standard treatment consists of an extensive cytoreductive surgery followed with adjuvant chemotherapy. This study aims to identify the common postoperative complications as well as to define predictive factors of their occurrence.MethodsThis study was conducted at Hôtel-Dieu University Hospital in Lebanon between October 2017 and October 2018. All patients older than 18-year-old who underwent cytoredcutive surgery for ovarian cancer were followed up from the postoperative admission in the intensive care unit till discharge from hospital or at least for 30 days. Correlations between perioperative characteristics and complications were searched and analyzed.Results40 patients were included. The mean age was 55 years old. The mean surgical complexity score was 5. Major complications have occurred in 32% of cases. They were associated with neoadjuvant chemotherapy (p = 0.009), elevated surgical complexity (p = 0.037), need for intraoperative transfusion and stay at intensive care unit more than 48 hours (p = 0.05). Complications were infectious, hemodynamic, pulmonary, digestive and surgical. Need for parenteral nutrition was significantly correlated with longer operative time and neoadjuvant chemotherapy. No correlation was found between occurrence of complications and the following parameters: age, stage, APACHE II score, Charlston Comorbidity index and preoperative albuminemia.ConclusionsCancer stage, neoadjuvant chemotherapy, high surgical complexity, need for transfusions, delayed extubation and stay at intensive care unit more than 48 hours were predictive factors of higher postoperative morbidity in patients receiving cytoreductive surgery for ovarian cancer.